{"symbol": "MGEN", "companyName": "Miragen Therapeutics Inc.", "exchange": "NASDAQ Capital Market", "industry": "Medical Diagnostics & Research", "website": "http://www.miragen.com", "description": "Miragen Therapeutics Inc is a clinical-stage biopharmaceutical company which engaged in discovering and developing proprietary RNA (Ribonucleic acid)-targeted therapeutics.", "CEO": "William S. Marshall", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Diagnostics & Research", "Medical Diagnostics & Research"]}